1. Medzhitov R, and Janeway CA. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91: 295-8. Review.
2. Abreu MT, Fukata M, and Arditi M. 2005. TLR signaling in the gut in health and disease. J. Immunol. 174: 4453-60. Review.
3. Kay RA. 1991. Microalgae as food and supplement. Crit. Rev. Food Sci. Nutr. 30: 555-73.
4. Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, and Seya T. 2002. Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina.platensis. Int. Immunopharmacol. 2: 423-34.
6. Masuda H, Akazawa T, Ebihara T, Hazeki K, Hazeki O, Matsumoto M, and Seya T. 2007. Anti-tumor natural killer cell activation induced by spirulina extract. Int. Immunopharmacol. (submitted).
7. Mishima T, Murata J, Toyoshima M, Fujii H, Nakajima M, Hayashi T, Kato T, and Saiki 1.1998. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis. Clin. Exp. Metastasis. 16: 541-50.
8. Cheng-Wu Z. 1994. Effect of polysaccharide and phycocyanin from spirulina on peripheral blood and hematopoietic system of bone marrow in mice. Proc. of Second Asia Pacific Conf. on Algal Biotech. (Abstr).
9. Hayashi O, Katoh T, and Okuwaki Y. 1994. Enhancement of antibody production in mice by dietary spirulina. J. Nutr. Science Vitaminol (Tokyo) 40: 431-41.
10. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, and Trinchieri G. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-33.
11. Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, and Tahara H. 2000. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Cancer Res. 60: 4838-44.
12. Matsuo-Tanabe M, Kawamoto T, Tanida S, Matsumoto M, and Seya T. 2004. Toll-like receptor 2 agonists with unique properties synthesized with reference to a product of Streptosporangium. Immunology 235-41.
13. KataokaT, andMisakiA. 1983. Glycolipids isolated from Spirulina maxima: structure and fatty acid composition. Agric. Biol. Chem. 47: 2349-55.
14. Means TK, Golenbock DT, and Fenton MJ. 2000. Structure and function of Toll-like receptor proteins. Life Sci. 68: 241-58. Review.
15. Uehori, J, Fukase K, Akazawa T, Uematsu T, Akira S, Funami S, Shingai K, Matsumoto I, Azuma M, Toyoshima K, Kusumoto S, and Seya T. 2005. Dendritic cell maturation induced by muramyl dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation. J. Immunol. 174: 7096-103.
16. Zhang S, Xie J, Zhang J, Zhao J, and Jiang L. 1999. Electron spin resonance studies on photosensitized formation of hydroxyl radical by C-phycocyanin from Spirulina platensis. Biochim. Biophys. Acta 1426: 205-11.
17. Miranda MS, Cintra RG, Barros SB, and Filho J. 1998. Antioxidant activity of the microalga Spirulina maxima. Braz. J. Med. Biol. Res. 31: 1075-9.
18. Romay C, Ledon N, and Gonzalez R. 1999. Phycocyanin extract reduces leuko-triene B4 levels in arachidonic acid-induced mouse-ear inflammation test. J. Pharm. Pharmacol. 51: 641-2.
19. Schwartz JL, Shklar G, Reid S, and Tricker D. 1988. Prevention of experimental oral cancer by extracts of Spirulina-Dunaliella algae. Nutr. Cancer 11: 127-34.
Li ZY, Li YG, Guo SY, Li L, and Zhang SL. 2000. Study of the factors of Cr(III) bioaccumulation on Spirulina platensis. Sheng. Wu. Gong. Cheng. Xue. Bao. 16: 108-12.
Seya T, Akazawa T, Matsumoto M, Begum NA, Azuma I, and Toyoshima K. 2003. Innate immune therapy for cancer: application of BCG-CWS and spirulina to patients with lung cancer. Anticancer Res. 23: 4369-76. Review.
Mathew B, Sankaranarayanan R, Nair PP, Varghese C, Somanathan T, Amma BP, Amma NS, and Nair MK. 1995. Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. Nutr. Cancer 24: 197-202.
Hayashi K, HayashiT, and KojimaI. 1996. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of antiherpes simplex virus and anti-human immunodeficiency virus activities. AIDS Res. Hum. Retroviruses 12: 1463-71.
Ayehunie S, Belay A, BabaTW, and Ruprecht RM. 1998. Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis (Arthrospira platensis). J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 18: 7-12.
Hazeki K, Hazeki O, Matsumoto M, and Seya T. 2003. Toll signaling induced by Spirulina extract in human myeloid dendritic cells. Jpn Soc. Immunol. (Proceedings). 33: 127 (Abstr).
TanakaK, TomitaY, TsurutaM, KonishiF, OkudaM, Himeno K, andNomoto K. 1990. Oral administration of Chlorella vulgaris augments concomitant antitumor immunity. Immunopharmacol. Immunotoxicol. 12: 277-91.
BorchersAT, Stern JS, HackmanRM, KeenCL, and Gershwin ME. 1999. Mushrooms, tumors, and immunity. Proc. Soc. Exp. Biol. Med. 221: 281-93. Chang R. 1996. Functional properties of edible mushrooms. Nutr. Rev. 54: S91-3. Ebina T, and Fujimiya Y. 1998. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice. Biotherapy 11: 259-65.
Iwasaki A, and Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-95. Review.
Hayashi A, Doi O, Azuma I, and Toyoshima K. 1998. Immunofriendly use of BCG-cell wall skeleton remarkably improves the survival rate of various cancer patients. Proc. Jpn. Acad. 74(B): 50-8.
Seya T, Matsumoto M, Akazawa T, and Kodama K. 2006. Advance of adjuvant-augmented immunetherapy for cancer. 65th Annual meeting Jpn Cancer Assoc. (Proceedings). 249 (Abstr).
Akazawa T, Masuda H, Saeki Y, Matsumoto M, Takeda K, Akira S, Azuma I, Toyoshima K, and Seya T. 2004. Adjuvant-mediated tumor regression and tumor-specific CTL induction are impaired in MyD88-deficient mice. Cancer Res. 64: 757-64. Uehori J, Tsuji S, Matsumoto M, Kawata C, Takeuchi T, Akira S, Azuma I, Toyoshima K, and Seya T. 2003. Simultaneous blocking of human Toll-like receptor 2 and 4 suppresses myeloid dendritic cell maturation induced by Mycobac-terium bovis bacillus Calmette-Guerin (BCG)-peptidoglycan (PGN). Infect. Immun. 71: 4238-49.
Matsumoto M, SeyaT, Kikkawa S, Tsuji S, Shida K, Nomura M, Kurita-Taniguchi M, Ohigashi H, Yokouchi H, Takami H, Hayashi A, Azuma I, Masaoka T, Kodama K, and Toyoshima K. 2001. IFNy-producing ability in blood of patients with lung cancer: production of IL-12p40 and IL-18 in response to BCG-CWS. Int. Immunopharmacol. 1: 1559-69.
36. Akazawa T, Okuno M, Okuda Y, Tsujimura K, Takahashi T, Ikawa M, Okabe M, Ebi-hara T, Shingai M, Inoue N, Tanaka-Okamoto M, Ishizaki H, Miyoshi J, Matsumoto M, and Seya T. 2006. Antitumor NK activation induced by the Toll-like receptor3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc. Natl. Acad. Sci. USA. 104: 252-7.
37. Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A, Toyoshima K, Seya T. 2000. Maturation of human dendritic cells by cell-wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin: involvement of Toll-like receptors. Infect. Immun. 68: 6883-90.
38. Seya T, Akazawa T, Matsumoto M, Begum NA, Azuma I, and Toyoshima K. 2003. Innate immune therapy for cancer: application of BCG-CWS and spirulina to patients with lung cancer. Anticancer Res. 23: 4369-76. Review.
39. Seya T, Akazawa T, Tsujita T, and Matsumoto M. 2006. Application of Toll-like receptor agonists to vaccine adjuvant therapy. ECAM 3: 31-8. Review.
40. Abreu MT, Fukata M, and Arditi M. 2005. TLR signaling in the gut in health and disease. J. Immunol. 174: 4453-60. Review.
Was this article helpful?
Find out why long exhausting workouts may do more harm than good. Most of the body-building workout and diet regimens out there are designed for the guys that gain muscle and fat easily. They focus on eating less and working out more in order to cut the excess fat from their bodies while adding needed muscle tone.